Lenalidomide for Refractory Cutaneous Manifestations of Pediatric Systemic Lupus Erythematosus

    November 2016 in “ Lupus ”
    Eveline Y. Wu, Laura E. Schanberg, E C Wershba, C. Egla Rabinovich
    Studysummary In this retrospective study of adolescents with recalcitrant cutaneous lupus, lenalidomide treatment resulted in complete or near resolution of skin symptoms within 6 months, while allowing for a reduction in prednisone dosage.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on europepmc.org →
    Discuss this study in the Community →